Association Between the Severity of Chronic Obstructive Pulmonary Disease and the Probability of Pulmonary Hypertension In a Tertiary Hospital

Authors

  • Friska Handayani Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Andalas, M. Djamil General Hospital, Padang
  • Deddy Herman Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Andalas, M. Djamil General Hospital, Padang
  • Dewi Wahyu Fitrina Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Andalas, M. Djamil General Hospital, Padang

DOI:

https://doi.org/10.36497/jri.v45i2.873

Keywords:

Brinkman index, COPD, pulmonary hypertension

Abstract

Background: Chronic obstructive pulmonary disease (COPD) patients with pulmonary hypertension (PH) have a poor prognosis, which worries doctors. The prevalence of COPD-related PH is unclear. The lack of anatomical criteria for right ventricular hypertrophy may explain research variance. Only type 1 PH patients undergo direct right cardiac catheterization of pulmonary artery pressure.

Methods: A cross-sectional analytical descriptive study examined stable COPD patients visiting the pulmonary department at M. Djamil Hospital, Padang, from November 2023 to February 2024 for PH probability.

Results: This study included 64 participants, with a majority aged between 40 and 65 years (59.4%), a significant proportion male (82.8%), and a junior high school (29.7%) level of education. Most of the subjects smoked (81.2%), had severe Brinkman Index (75.0%), had severe GOLD criteria (50.0%), and had no comorbidities (53.1%). No correlation was found between the severity of COPD and the likelihood of PH (P=0.591). The Brinkman Index of smokers was a significant risk factor for PH (P=0.010; OR=1.282; 95% CI=0.260-6.315). 

Conclusion: There is no significant association between the severity of COPD according to GOLD criteria and the likelihood of PH.

Downloads

Download data is not yet available.

References

1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal. 2019;53(1):1801913.

2. Agus AW, Adrianison A, Siswanty D, Yunus F, Zahtamal Z. Chronic obstructive pulmonary disease with incidence of heart failure and its influencing factors. Jurnal Respirasi. 2022;8(1):7–14.

3. Safitri Y, Siregar AA, Mukhtar Z. Hubungan derajat keparahan penyakit paru obstruktif kronik dengan temuan patologis ekokardiografi di Rumah Sakit Umum Pusat Haji Adam Malik Medan. Universitas Sumatera Utara Press. [Medan]: Universitas Sumatera Utara; 2019.

4. Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest. 2007;131(1):94–100.

5. Zhang L, Liu Y, Zhao S, Wang Z, Zhang M, Zhang S, et al. The incidence and prevalence of pulmonary hypertension in the COPD population: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:1365–79.

6. Oldroyd SH, Manek G, Bhardwaj A. Pulmonary hypertension. StatPearls [Internet], editor. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. 7–89 p.

7. Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2011;4(3):257–65.

8. Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA. Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci. 2012;9(6):406–12.

9. Basak S, Mukherjee R, Chowdhury S, Roy S, Banerjee R, Bhattacharya R. Evaluation of cardiac function in COPD patients and correlation with disease severity: a cross sectional study. Asian J Med Sci. 2021;12(3):14–9.

10. Naeije R, D’Alto M. Sex matters in pulmonary arterial hypertension. Eur Respir J. 2014;44(2):553–4.

11. Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM. Sex and haemodynamics in pulmonary arterial hypertension. Eur Respir J. 2014;43(2):523–30.

12. Rodriguez-Arias JJ, García-Álvarez A. Sex differences in pulmonary hypertension. Front Aging. 2021;2:727558.

13. Luca E, Bodrug N. The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review. Egypt J Intern Med. 2022;34:47.

14. Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, et al. Impact of education on COPD severity and all-cause mortality in lifetime never-smokers and longtime ex-smokers: results of the cosyconet cohort. Int J Chron Obstruct Pulmon Dis. 2020;15:2787–98.

15. Mohammed YM, ElShahid GS, Osman NM, Abd ElHameed NQ. Cardiac evaluation of patients with chronic obstructive pulmonary disease using echocardiography. Egyptian Journal of Bronchology. 2019;13:12–6.

16. Jain S, Jain A, MKhoja A. Effect of smoking on pulmonary hypertension: prospective observational study. Sch J App Med Sci. 2019;7(7):2335–8.

17. Imaizumi Y, Eguchi K, Kario K. Lung disease and hypertension. Pulse. 2014;2(1–4):103–12.

18. Kim SH, Park JH, Lee JK, Heo EY, Kim DK, Chung HS. Chronic obstructive pulmonary disease is independently associated with hypertension in men: a survey design analysis using nationwide survey data. Medicine (Baltimore). 2017;96(19):e6826.

19. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85.

20. Badesch DB, Champion HC, Gomez Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S55–66.

21. Cassady SJ, Reed RM. Pulmonary hypertension in COPD: a case study and review of the literature. Medicina (B Aires). 2019;55(8):432.

22. Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003;21(5):892–905.

23. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008 Nov;32(5):1371–85.

24. Aguirre-Franco C, Torres-Duque CA, Salazar G, Casas A, Jaramillo C, Gonzalez-Garcia M. Prevalence of pulmonary hypertension in COPD patients living at high altitude. Pulmonology. 2024;30(3):247–53.

25. Medrek SK, Sharafkhaneh A, Spiegelman AM, Kak A, Pandit LM. Admission for COPD exacerbation is associated with the clinical diagnosis of pulmonary hypertension: results from a retrospective longitudinal study of a veteran population. COPD. 2017;14(5):484–9.

26. Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, et al. Pulmonary hypertension in chronic lung disease and hypoxia. European Respiratory Journal. 2020;53(1):1801914.

27. Blanco I, Tura-Ceide O, Peinado VI, Barberà JA. Updated perspectives on pulmonary hypertension in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1315–24.

Downloads

Published

2025-04-20

Issue

Section

Original Article

How to Cite

Association Between the Severity of Chronic Obstructive Pulmonary Disease and the Probability of Pulmonary Hypertension In a Tertiary Hospital. (2025). Jurnal Respirologi Indonesia, 45(2), 106–112. https://doi.org/10.36497/jri.v45i2.873

Similar Articles

1-10 of 150

You may also start an advanced similarity search for this article.